Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Liping Li, Jing Yang, Lihua Ren, Ning Su, Yichuan Fang & Yi Lin. (2013) Invariant NKT cells increase lipopolysacchride-induced pregnancy loss by a mechanism involving Th1 and Th17 responses. The Journal of Maternal-Fetal & Neonatal Medicine 26:12, pages 1212-1218.
Read now
Read now
Sungjune Kim, Saif Lalani, Vrajesh V Parekh, Lan Wu & Luc Van Kaer. (2008) Glycolipid ligands of invariant natural killer T cells as vaccine adjuvants. Expert Review of Vaccines 7:10, pages 1519-1532.
Read now
Read now
Hsiu-Ting Tsai, Tzu-Hsin Tsai, Tsong-Ming Lu & Chi-Chiang Yang. (2008) Immunopathology of Hepatitis B Virus Infection. International Reviews of Immunology 27:6, pages 427-446.
Read now
Read now
Articles from other publishers (23)
Alex Look, Daniel Burns, Ivo Tews, Ali Roghanian & Salah Mansour. (2023) Towards a better understanding of human iNKT cell subpopulations for improved clinical outcomes. Frontiers in Immunology 14.
Crossref
Crossref
Samuel Zeng, Zhe Li, Derek Lee & Lili Yang. 2023. NK Cells in Cancer Immunotherapy: Successes and Challenges. NK Cells in Cancer Immunotherapy: Successes and Challenges
385
401
.
Cheng Nong, Pengbo Guan, Li Li, Huiyuan Zhang & Hongbo Hu. (2022) Tumor immunotherapy: Mechanisms and clinical applications. MedComm – Oncology 1:1.
Crossref
Crossref
Zhe Li, Derek Lee, Samuel Zeng & Lili Yang. 2021. Successes and Challenges of NK Immunotherapy. Successes and Challenges of NK Immunotherapy
63
80
.
Susana Sainz de la Maza, Silvia Medina, Noelia Villarrubia, Lucienne Costa-Frossard, Enric Monreal, Amalia Tejeda-Velarde, Eulalia Rodríguez-Martín, Ernesto Roldán, José C. Álvarez-Cermeño & Luisa M. Villar. (2019) Factors associated with dimethyl fumarate-induced lymphopenia. Journal of the Neurological Sciences 398, pages 4-8.
Crossref
Crossref
Marley C. Caballero Van Dyke & Floyd L. WormleyJrJr. (2018) A Call to Arms: Quest for a Cryptococcal Vaccine. Trends in Microbiology 26:5, pages 436-446.
Crossref
Crossref
Luc Van Kaer & Lan Wu. (2018) Therapeutic Potential of Invariant Natural Killer T Cells in Autoimmunity. Frontiers in Immunology 9.
Crossref
Crossref
Daniëlle Krijgsman, Marianne Hokland & Peter J. K. Kuppen. (2018) The Role of Natural Killer T Cells in Cancer—A Phenotypical and Functional Approach. Frontiers in Immunology 9.
Crossref
Crossref
Shiny Nair & Madhav V. Dhodapkar. (2017) Natural Killer T Cells in Cancer Immunotherapy. Frontiers in Immunology 8.
Crossref
Crossref
Luc Van Kaer, Lan Wu & Vrajesh V. Parekh. (2015) Natural killer T cells in multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis. Immunology 146:1, pages 1-10.
Crossref
Crossref
Stuart P. Berzins & David S. Ritchie. (2014) Natural killer T cells: drivers or passengers in preventing human disease?. Nature Reviews Immunology 14:9, pages 640-646.
Crossref
Crossref
Vrajesh V. Parekh, Lan Wu, Danyvid Olivares-Villagómez, Keith T. Wilson & Luc Van Kaer. (2013) Activated Invariant NKT Cells Control Central Nervous System Autoimmunity in a Mechanism That Involves Myeloid-Derived Suppressor Cells. The Journal of Immunology 190:5, pages 1948-1960.
Crossref
Crossref
Pooja Arora, Erin L. Foster & Steven A. Porcelli. 2013. The New Paradigm of Immunity to Tuberculosis. The New Paradigm of Immunity to Tuberculosis
199
223
.
Francesco Dazzi, Luciene Lopes & Ling Weng. (2012) Mesenchymal stromal cells: a key player in ‘innate tolerance’?. Immunology 137:3, pages 206-213.
Crossref
Crossref
Ying-yi LuanYong-ming YaoZhi-yong Sheng. (2012) Update on the Immunological Pathway of Negative Regulation in Acute Insults and Sepsis. Journal of Interferon & Cytokine Research 32:7, pages 288-298.
Crossref
Crossref
Luc Van Kaer, Vrajesh V Parekh & Lan Wu. (2011) Invariant NK T cells: potential for immunotherapeutic targeting with glycolipid antigens. Immunotherapy 3:1, pages 59-75.
Crossref
Crossref
Luc Van Kaer, Vrajesh V. Parekh & Lan Wu. (2010) Invariant natural killer T cells: bridging innate and adaptive immunity. Cell and Tissue Research 343:1, pages 43-55.
Crossref
Crossref
C Y Wu, Y Feng, G C Qian, J H Wu, J Luo, Y Wang, G J Chen, X K Guo & Z J Wang. (2010) α-Galactosylceramide protects mice from lethal Coxsackievirus B3 infection and subsequent myocarditis. Clinical and Experimental Immunology 162:1, pages 178-187.
Crossref
Crossref
Jean-Marc Doisne, Chantal Becourt, Latiffa Amniai, Nadia Duarte, Jean-Benoît Le Luduec, Gérard Eberl & Kamel Benlagha. (2009) Skin and Peripheral Lymph Node Invariant NKT Cells Are Mainly Retinoic Acid Receptor-Related Orphan Receptor γt+ and Respond Preferentially under Inflammatory Conditions. The Journal of Immunology 183:3, pages 2142-2149.
Crossref
Crossref
L. Wu, C. L. Gabriel, V. V. Parekh & L. Van Kaer. (2009) Invariant natural killer T cells: innate-like T cells with potent immunomodulatory activities. Tissue Antigens 73:6, pages 535-545.
Crossref
Crossref
Vrajesh V. Parekh, Saif Lalani, Sungjune Kim, Ramesh Halder, Miyuki Azuma, Hideo Yagita, Vipin Kumar, Lan Wu & Luc Van Kaer. (2009) PD-1/PD-L Blockade Prevents Anergy Induction and Enhances the Anti-Tumor Activities of Glycolipid-Activated Invariant NKT Cells. The Journal of Immunology 182:5, pages 2816-2826.
Crossref
Crossref
Silvia Fallarini, Tiziana Paoletti, Luigi Panza & Grazia Lombardi. (2008) α-Galactosylceramide modulates the induction of indoleamine 2,3-dioxygenase in antigen presenting cells. Biochemical Pharmacology 76:6, pages 738-750.
Crossref
Crossref
Sungjune Kim, Saif Lalani, Vrajesh V. Parekh, Tiffaney L. Vincent, Lan Wu & Luc Van Kaer. (2008) Impact of bacteria on the phenotype, functions, and therapeutic activities of invariant NKT cells in mice. Journal of Clinical Investigation.
Crossref
Crossref